Author:
Bigger B W,Siapati E K,Mistry A,Waddington S N,Nivsarkar M S,Jacobs L,Perrett R,Holder M V,Ridler C,Kemball-Cook G,Ali R R,Forbes S J,Coutelle C,Wright N,Alison M,Thrasher A J,Bonnet D,Themis M
Publisher
Springer Science and Business Media LLC
Subject
Genetics,Molecular Biology,Molecular Medicine
Reference42 articles.
1. Sultan Y . Prevalence of inhibitors in a population of 3435 hemophilia patients in France. French Hemophilia Study Group. Thromb Haemost 1992; 67: 600–602.
2. Kamiya T, Nagao T, Yoshioka A . A retrospective study on the development of inhibitors in Japanese hemophiliacs (second report, 1994 study). Research Group of Blood Products for Hemophilia Inhibitor. Rinsho Ketsueki 1998; 39: 402–404.
3. Ljung R, Petrini P, Tengborn L, Sjorin E . Haemophilia B mutations in Sweden: a population-based study of mutational heterogeneity. Br J Haematol 2001; 113: 81–86.
4. Ghosh K, Shetty S, Kulkarni B, Nair S, Pawar A, Khare A et al. Development of inhibitors in patients with haemophilia from India. Haemophilia 2001; 7: 273–278.
5. Knobe KE, Sjorin E, Tengborn LI, Petrini P, Ljung RC . Inhibitors in the Swedish population with severe haemophilia A and B: a 20-year survey. Acta Paediatr 2002; 91: 910–914.
Cited by
48 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献